AUTO1 Expands Partnership With Volvo

AUTO1.com, Europe's largest wholesale platform for used cars and part of AUTO1 Group SE, said it has expanded its partnership with Volvo. Registered Volvo dealers in Germany can now digitally evaluate trade-ins even more easily via the native AUTO1 EVA app and sell them via AUTO1.com.

AUTO1.com said that it is expanding its cooperation with authorized dealers and making its remarketing technologies available to car dealerships throughout Germany and Europe.

Through this cooperation, AUTO1 Group gains another sourcing channel and thus strengthens its offering on the digital platforms.

Volvo partners are digitizing the purchase and sale of trade-ins by allowing customers to request a price for their trade-ins via volvocars.com and then book an appointment with the local dealer.

Using the AUTO1 EVA app, the Volvo dealer can document the trade-in at the on-site appointment and, after the purchase, directly sell it to over 60,000 dealers across Europe at the touch of a button via AUTO1.com.

Vehicle inspection, primarily through simplified but detailed damage, photo, and video recording, is now possible in under 15 minutes, AUTO1 said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of LM Ericsson were gaining more than 7 percent in Swedish trading as well as in pre-market activity on Nasdaq, after the telecom equipment maker reported Tuesday higher profit and sales in its fourth quarter with strong demand. Further, the company lifted its full-year dividend, and maintained targets for fiscal 2022 EBIT growth as well as long-term target of EBITA margin. Twitter Inc. said it is expanding engineering center in Singapore, its Asia Pacific headquarters. The number of engineers there will be doubled to over 100 staff in 2023. Focused on product innovations and improvements, the new hires will work from Singapore on global initiatives for Twitter. These new technical hires will span roles in engineering, data science, machine learning and product... The U.S. Food and Drug Administration (FDA) has granted approval and reissued the revised Emergency Use Authorization (EUA) to Gilead Sciences Inc. for antiviral drug Veklury (remdesivir) to treat certain non-hospitalized adults and pediatric patients with mild-to-moderate COVID-19 disease.
Follow RTT